Recall Record

Earth City, MO, United States

Legacy Pharmaceutical Packaging LLC recalls

5 recalls recorded since 2018, most recently on 11 December 2023. 3 are listed as ongoing. Status and classification are as published by the FDA.

Recalls5
Ongoing (FDA)3
Terminated or completed2
Class I (FDA)0

Ongoing Class II Drugs

Recall started
11 December 2023
Reason
CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.
Distribution
CA and AR
Initiated
Voluntary: Firm initiated
Recall number
D-0205-2024

Terminated Class III Drugs

Recall started
24 September 2020
Terminated
8 November 2022
Reason
Presence of Foreign Tablets/Capsules: Metformin 1000mg with different imprint was found in bottles.
Distribution
Walmart distribution centers in GA and AR
Initiated
Voluntary: Firm initiated
Recall number
D-1626-2020

Ongoing Class II Drugs

Recall started
24 April 2019
Reason
CGMP Deviations: Detection of trace amounts of N-Methylnitrosobutyric acid (NMBA) impurity found in the Active Pharmaceutical Ingredient (API)
Distribution
TN, AZ
Initiated
Voluntary: Firm initiated
Recall number
D-1263-2019

Ongoing Class II Drugs

Recall started
1 March 2019
Reason
CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) detected
Distribution
Wal-Mart distribution centers in AR, CA, GA, IN and MD
Initiated
Voluntary: Firm initiated
Recall numbers
D-1050-2019, D-1048-2019, D-1049-2019

Terminated Class II Drugs

Recall started
1 March 2019
Terminated
29 September 2023
Reason
CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) detected.
Distribution
AZ, IN, TN
Initiated
Voluntary: Firm initiated
Recall number
D-1075-2019

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.